Virginia Tech researchers began testing campus wastewater for COVID-19
On Sept. 3, 2020, a team of Virginia Tech researchers announced that they will begin testing wastewater at…
-
-
Roche received FDA Emergency Use Authorization for the cobas SARS-CoV-2 & influenza A/B test for use on cobas 6800/8800 systems
On Sept. 3, 2020, Roche announced that the cobas SARS-CoV-2 & Influenza A/B Test for use on the…
-
OPKO Health’s BioReference Laboratories announced New York City Schools COVID-19 testing program
On Sept. 2, 2020, BioReference Laboratories, an OPKO Health company, began testing New York City principals, teachers and…
-
Aegis Sciences awarded $66 million NIH grant to rapidly expand COVID-19 test capacity
On Sept. 2, 2020, Aegis Sciences announced that it had been selected to participate in the National Institutes…
-
PathGroup selected by NIH to become RADx program ‘mega-lab’ for COVID-19 testing
On Sept. 2, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
-
Biotechnology | Diagnostics | HIV | Infectious Disease | Non-Profit Research | Organ Transplant | Therapeutics
UT Southwestern performed first HIV-positive-to-HIV-positive organ transplant in Texas
On Sept. 2, 2020, less than three weeks after getting on an organ transplant list for HIV-positive patients,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | IRB | NIH
Sonic Healthcare expand COVID-19 testing capacity in US in collaboration with NIH RADx Initiative
On Sept. 2, 2020, Sonic Healthcare USA was awarded a contract from the National Institutes of Health (NIH)…
-
NIH awarded MicroGEM $409 million to fast-track rapid, no-lab COVID-19 saliva test
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…
-
Custom face shields aimed to block droplets, tackled COVID-19 for football players
On Sept. 2, 2020, researchers from the Virginia Tech Helmet Lab announced the development of a football helmet…
-
NIH to boost national COVID-19 testing capacity
On Sept. 2, 2020, the National Institutes of Health (NIH) announced $129.3 million in scale-up and manufacturing support…
-
US Army uniquely poised to battle global pandemic
On Sept. 2, 2020, U.S. Army Medical Research and Development Command continues to combat the virus on several…
-
Broad Institute provided COVID-19 screening for students, faculty and staff at more than 100 colleges and universities
On Sept. 2, 2020, Broad Institute of MIT and Harvard announced it had partnered with 108 public and…
-
NIH-supported study to track prevalence and impact of SARS-CoV-2 among pregnant women in low- and middle-income countries
On Sept. 1, 2020, the National Institutes of Health announced that it had launched a study to track…
-
Scientists used genomics to discover an ancient dog species that may teach us about human vocalization
On Aug. 31, 2020, in a study published in PNAS, researchers used conservation biology and genomics to discover…
-
Biotechnology | Diagnostics | Disease | NIH
New gene associated with reduced risk for cirrhosis
On Aug. 31, 2020, An international team of scientists supported by the National Institute on Alcohol Abuse and…
-
UConn launched funding program for COVID-19 research
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
-
Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratory
On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
-
NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer research
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
-
White House announced plan to deploy 150 million rapid tests in 2020
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
-
International research alliance launched to boost pandemic preparedness
On Aug. 27, 2020, scientists at Scripps Research announced they were partnering with peers in the U.S. and…
-
AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model
On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…
-
Rapid diagnostic detected Lassa and Ebola in real-time
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
-
How SARS-CoV-2 spread across greater Boston during pandemic’s first wave
On Aug. 25, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, the Massachusetts…
-
Genomic analysis revealed many animal species may be vulnerable to SARS-CoV-2 infection
On Aug. 24, 2020, humans are not the only species facing a potential threat from SARS-CoV-2, the novel…
-
AXIM Biotechnologies signed exclusive licensing, manufacturing and distribution agreement for production of COVID-19 rapid neutralizing antibody test
On Aug. 24, 2020, AXIM Biotechnologies announced that it had signed an exclusive limited licensing, manufacturing and distribution…
-
Man in Hong Kong was the first confirmed case of Coronavirus reinfection
On Aug. 24, 2020, Hong Kong University researchers reported that a 33-year-old man in Hong Kong had been…
-
CDC published ACIP 2020-21 influenza vaccination recommendations
On Aug. 21, 2020, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
JAMA reported on evaluation for SARS-CoV-2 in breast milk from infected women
On Aug. 19, 2020, JAMA reported that to date, SARS-CoV-2 has not been isolated from breast milk, and…
-
NIH imposed ‘outrageous’ conditions on resuming coronavirus grants
On Aug. 19, 2020, the National Institutes of Health (NIH) announced it was requiring a small nonprofit research…
-
Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofia SARS…
